---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-113265"
form_type: "8-K"
ticker: "HCWB"
cik: "0001828673"
company_name: "HCW Biologics Inc."
filed_at: "2025-09-05T23:59:59+00:00"
generated_at: "2026-05-17T08:04:01.472992+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# HCW Biologics says licensee WY Biotech will likely miss $7M upfront payment; negotiations ongoing

## Summary
- WY Biotech likely won't meet Sept 30, 2025 deadline for $7.0M upfront license fee under exclusive agreement.
- WY Biotech has not finalized CDMO and investor agreements, delaying payment as previously reported.
- Company and WY Biotech are negotiating potential further revisions and additions to the license agreement.
- Delay follows earlier extension from July 18, 2025; no revised payment date has been set.

## SEC filing metadata
- accession: 0000950170-25-113265
- form_type: 8-K
- ticker: HCWB
- cik: 0001828673
- company_name: HCW Biologics Inc.
- filed_at: 2025-09-05T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1828673/000095017025113265/0000950170-25-113265-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1828673/000095017025113265/hcwb-20250902.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-113265
- JSON: https://secwatch.observer/filing/0000950170-25-113265.json
- Plain text: https://secwatch.observer/filing/0000950170-25-113265.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.